Alkermes CEO on Profits & New Drugs

[cnbc 3000089408]

Richard Pops, Alkermes CEO, discusses getting FDA approval for developing better drugs, with Mad Money’s Cramer.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply